Article: Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study Published in: Lancet HIV. 2021;8(2):e87-e95 https://doi.org/10.1016/S2352-3018(20)30304-0 Authors: Baeten JM, Palanee-Phillips T,...
Article and Study Summary Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study Published in: Lancet. 2020;396 (10267):1994-2005...
Andrew T Boyd, Dennis Kenyi Lodiongo, John Mondi Benson, Shambel Aragaw,cMargaret Semira Pasquale, Habtamu Ayalneh, Robert Olemukan, Isaac Avaku, Nicholas Baabe, Victoria Achut, Helen Chuna & Sudhir Bungab Bull World Health Organ 2021;99:34–40 | doi:...
Reif LK, Abrams EJ, Arpadi S, Elul B, McNairy ML, Fitzgerald DW, Kuhn L. AIDS Behav. 2020 Oct;24(10):2797-2810. doi: 10.1007/s10461-020-02822-4. PMID: 32152815; PMCID: PMC7223708. Abstract Adolescents and youth living with HIV have poorer antiretroviral treatment...
Shiau, S., Evans, H., Strehlau, R., Shen, Y., Burke, M., Liberty, A., Coovadia, A., Abrams, E. J., Yin, M. T., Violari, A., Kuhn, L., & Arpadi, S. M. (2020). The Journal of pediatrics, S0022-3476(20)30956-2. Advance online publication....
